Martin Reeves has over 30 years’ experience in the pharmaceutical industry and has advised several companies on their corporate development strategy.
He was Vice President and Head of Sourcing in Teva’s Global Branded Products Division based in the US and spent 14 years at Cephalon Inc, a leading US specialty pharmaceutical company, where he was Vice President of Business Development, Strategic Planning & Project Management. During this period he played a key part in the growth of company and latterly via a licencing and acquisition strategy, built Cephalon’s product pipeline which lead to the successful sale of Cephalon to Teva for $6.3B in 2011.
Prior to his experience at Cephalon, he had worked in Research and Development in several positions including Director, Project Management at Wyeth US and as a Project Director at SmithKline Beecham UK.
He is a graduate of London University having gained his degree in Biochemistry in 1980.